China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Pharmaceutical Group Ltd. has announced major changes to its leadership team, effective from August 29, 2024. Mr. Han Yuewei has stepped down as the non-executive Director and Chairman of the Board, while Mr. Bai Xiaosong has resigned as CEO to assume the role of Chairman. Additionally, Ms. Deng Rong, the CFO, will join the Corporate Governance Committee.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.